Oncologic Drugs Advisory Committee
Executive Summary
Discussion of single-patient use of non-approved oncology drugs and biologics will continue during the June 7-8 meeting. The committee discussed the topic in December (1"The Pink Sheet" Dec. 18, 2000, p. 21)